Induction of Apoptosis by (-)-epigallocatechin-3-gallate in HL-60 Cells |
이해미
(연세대학교 식품영양학과)
김연정 (연세대학교 식품영양학과) 박태선 (연세대학교 식품영양학과) |
1 | Chung LY, Cheung TC, Kong SK, Fung KP, Choy YM, Chan ZY, Kwok TT. Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci 68: 1207-1214, 2001 DOI ScienceOn |
2 | Chen W, Dong Z, Valcic S, Timmermann BN, Gowden GT. inhibition of ultraviolet B -induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line. Mol Carcinog 24: 79-84, 1999 DOI ScienceOn |
3 | Ahmad N, Gupta S, Mukhtar H. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Arch Biochem Biophys 376: 338-346, 2000 DOI ScienceOn |
4 | Gupta S, Hussain T, Mukhtar H. Molecular pathway for (-)-epigallocatechin-3-gallate -induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 410(1): 177-185, 2003 DOI ScienceOn |
5 | Suzuki N, Urano J, Tamanol F. Farnesyltransferase inhibitors induce cytochrome C release and caspase 3 activation preferentially in transformed cells. Proc Natl Acad Sci USA 95: 15356-15361, 1998 DOI ScienceOn |
6 | Kroemer G, Martinez AC, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 18: 44-51, 1997 DOI ScienceOn |
7 | Mukhtar H, Ahmad N. Mechanism of cancer chemopreventive activity of green tea, Proc Soc Exp Biol Med 220: 234-238, 1999 DOI ScienceOn |
8 | Samali A, Zhivotoxvsky B, Jones D, Nagata S, Orrenius S. Apoptosis: cell death defined by caspase activation. Cell Death Differ 6: 495-496, 1999 DOI ScienceOn |
9 | Yang GY, Liao J, Kim K, Yurkow EJ, Yang CS. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 19: 611-616, 1998 DOI ScienceOn |
10 | Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346-347, 1994 DOI ScienceOn |
11 | Nicholson DW, Ali A, Thomberry NA, Vaillancourt JP, Ding CK Gallant M, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller DK. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43, 1995 DOI ScienceOn |
12 | Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M, Kroemer G. Mitochondrial permeability is a central coordinating event of apoptosis. J Exp Med 184: 1155-1160, 1996 DOI ScienceOn |
13 | Yoo HG, Shin BA, Park JC, Kim HS, Kim WJ, Chay KO, Ahn BW, Park RK, Ellis LM, Jung YD. Induction of apoptosis by the green tea flavonol (-)-epigallocatechin-3-gallate in human endothelial ECV 304 cells. Anticancer Res 22(6A): 3373-8, 2002 |
14 | Baliga BC, Kumar S. Role of Bcl-2 family of proteins in malignancy. Hematol Oncol 20(2) : 63-74, 2002 DOI ScienceOn |
15 | Hsu SD, Singh BB, Lewis JB, Borke JL, Dickinson DP, Drake L, Caughman GB, Schuster GS. Chemoprevention of oral cancer by green tea. Gen Dent 50(2): 140-6, 2002 |
16 |
Preventing neural tube defects:the importance of periconceptional folic acid supplements
/
DOI |
17 |
Genetic Polymorphisms of methylenetetrahydrofolate reductase (MTHER) and methionine synthase reductase (MTRR) in ethnic populations in Texas;A report of a novel MTHER polymorlhic site, G1793A
/
DOI |
18 |
Homocysteine metabolism in pregnancies complicated by neural tube defects
/
DOI |
19 |
Homocysteine and methylmalonic acid levels in pregnant Npali women. Should cobalamin supplementation be considered?
/
DOI ScienceOn |
20 |
Hyperhomocusteinaemia
/
|
21 |
Plasma total homocysteine, pregnancy complications and adverse pregnancy outcomes:the Hordaland Homocysteine
/
|
22 |
Changes in homocysteine levels during normal pregnancy
/
DOI |
23 |
Relationship between vitamin B6 status of maternal-umbilical cord plasma and pregnancy outcomes
/
|
24 |
Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a histtory of preeclampsia or fetal growth restriction
/
DOI |
25 |
Serum folate levels of maternal-umbilical cord blood and pregnancy outcomes
/
과학기술학회마을 |
26 |
Biological and clinical implications of the MTHFR C666T polymorphism
/
DOI |
27 |
Homocysteine induces congenital defects of the heart and neural tube:effect of folic acid
/
DOI |
28 |
Hyperhomocysteinemia:A risk factor in women with unexplained recurrent early pregnancy loss
/
|
29 |
The placenta in maternal hylerhomocysteinaemia
/
DOI |
30 |
Protein-bound homocyst(e)ine
/
DOI |
31 |
Folic acid:influence on the outcome of pregnancy
/
|
32 |
The methionine synthase reductase (MTRR) A66G polymorphism is a movel genetic determinant of plasma homocysteine concenttrations
/
DOI |
33 |
Hyperthomocysteunemia:A risk factor for placental abruption or infarction
/
DOI |
34 |
Maternal vitamin B6 intake and vitamin B6 level in maternal, umbilical cord plasma and placenta
/
|
35 |
Hyperhomocysteinemia and pregnancy-review of our present understanding and therapeutic implications
/
DOI |
36 |
A candidate genetic risk factor for vascular disease:A common mutation in methylenetetrahydrofolate reductase
/
DOI ScienceOn |
37 |
Determination of free and total homocysteine in human plasma by high performance liquid chromatograpfy with fluorescence detection
/
DOI |
38 |
Is homocysteine a biomarker for identifying women at risk of complications and adverse pregnancy outcomes?
/
|
39 |
Acute hyperhomocysteinaemia and endothelial dysfunction
/
DOI ScienceOn |
40 |
Intrauterine groeth retardation, perinatal death, and maternal homocysteine levels
/
|
41 |
Neural tube defects and a disturbed folate dependent homocyssteine metabolism
/
|
42 |
A polymorphism (80G→A) in the reduced folate carrier gene and its associations with folate atatus and homocysteinemia
/
DOI |
43 |
A new HPLC-nethod for the simultaneous determination of B1-,B2- and B6-vitamers in serum and whole blood
/
|